32,857 reports of this reaction
3.9% of all Dupixent reports
#5 most reported adverse reaction
INJECTION SITE PAIN is the #5 most commonly reported adverse reaction for Dupixent, manufactured by Sanofi-Aventis U.S. LLC. There are 32,857 FDA adverse event reports linking Dupixent to INJECTION SITE PAIN. This represents approximately 3.9% of all 838,442 adverse event reports for this drug.
Patients taking Dupixent who experience injection site pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INJECTION SITE PAIN is moderately reported among Dupixent users, representing a notable but not dominant share of adverse events.
In addition to injection site pain, the following adverse reactions have been reported for Dupixent:
The following drugs have also been linked to injection site pain in FDA adverse event reports:
INJECTION SITE PAIN has been reported as an adverse event in 32,857 FDA reports for Dupixent. This does not prove causation, but indicates an association observed in post-market surveillance data.
INJECTION SITE PAIN accounts for approximately 3.9% of all adverse event reports for Dupixent, making it a notable side effect.
If you experience injection site pain while taking Dupixent, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.